Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/13/1998 | US5821089 Contacting prokaryotic or eukaryotic cell with growth medium containing trans-4-hydroxyproline or 3-hydroxyproline to incorporate analog into polypeptide produced by cell |
10/13/1998 | US5821081 Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides |
10/13/1998 | US5821075 Nucleotide sequences for novel protein tyrosine phosphatases |
10/13/1998 | US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections |
10/13/1998 | US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same |
10/13/1998 | US5821049 Contacting compound with test cell transfected with recombinant nucleic acid from dna or rna virus encoding transforming protein, scoring cell growth based on selected transformation characteristic |
10/13/1998 | US5821047 Fusing a gene encoding a protein of interest to the carboxy terminal domain of the gene iii coat protein of the filamentous phage m13; mutation to form library; expressed in low quantity on surface of phagemid particle |
10/13/1998 | US5820866 Product and process for T cell regulation |
10/13/1998 | US5820863 A non-naturally occuring non-rodent zona pellucida polypeptide which is the expression product of dna encoding a mammalian zona pellucia polypeptide having immunological cross-reactivity with zona pellucida protein encoded by dna |
10/13/1998 | US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting |
10/13/1998 | US5820858 Methods and compositions for inhibiting CD14 mediated cell activation |
10/13/1998 | US5820856 Treating bone marrow cells with gamma-irradiated modified cytotoxic t lymphoblastic leukemia cell line; bone marrow cells previously treated with cytokine(s) |
10/13/1998 | US5820847 Administering a diagnostic agent complexed with a targeting ligand of folates or receptor-binding derivatives; for transporting exogenous molecules into cells with folate receptors; drug delivery |
10/13/1998 | CA2120518C A method of identifying ligands and antagonists of ligands |
10/09/1998 | CA2234472A1 Vaccines |
10/08/1998 | WO1998044159A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | WO1998044149A1 Detection of dna damaging agents |
10/08/1998 | WO1998044142A1 Molecular marker for muscle stem cells |
10/08/1998 | WO1998044141A2 Insect expression vectors |
10/08/1998 | WO1998044139A1 Improved sar plant transformation process |
10/08/1998 | WO1998044138A1 Improvements relating to the specificity of gene expression |
10/08/1998 | WO1998044133A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | WO1998044132A1 VIRAL VECTORS HAVING CHIMERIC ENVELOPE PROTEINS CONTAINING THE IgG-BINDING DOMAIN OF PROTEIN A |
10/08/1998 | WO1998044128A1 Novel human serine carboxypeptidase |
10/08/1998 | WO1998044121A1 Modified adenoviral fiber and target adenoviruses |
10/08/1998 | WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
10/08/1998 | WO1998044118A1 Chemokine beta-6 |
10/08/1998 | WO1998044114A1 Calcium-binding protein similar to reticulocalbin |
10/08/1998 | WO1998044107A1 Diagnosis and prognosis of glaucoma |
10/08/1998 | WO1998044104A2 Flip gene and flip protein |
10/08/1998 | WO1998044103A2 Protein for inhibiting apoptosis |
10/08/1998 | WO1998044000A1 Recombinant protein c and protein s variants |
10/08/1998 | WO1998043686A1 Enzyme-mediated modification of fibrin for tissue engineering |
10/08/1998 | WO1998043679A1 Human embryonic germ cell line and methods of use |
10/08/1998 | WO1998043476A1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide |
10/08/1998 | WO1998025959A3 Secreted human proteins |
10/08/1998 | WO1998022104A3 Treatment of neurodegenerative conditions with nimesulide |
10/08/1998 | WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof |
10/08/1998 | WO1998018930A3 Streptococcus pneumoniae antigens and vaccines |
10/08/1998 | WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
10/08/1998 | DE19713530A1 Haemo-dynamically modulated reporter system comprises reporter gene under control of haemo-dynamically modulated promoter |
10/08/1998 | DE19713393A1 Flip-Gen und Flip-Protein Flip gene and flip-protein |
10/08/1998 | CA2559468A1 Insect expression vectors |
10/08/1998 | CA2285709A1 Molecular marker for muscle stem cells |
10/08/1998 | CA2285669A1 Flip gene and flip protein |
10/08/1998 | CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis |
10/08/1998 | CA2285622A1 Chemokine beta-6 |
10/08/1998 | CA2285565A1 Modified adenoviral fiber and target adenoviruses |
10/08/1998 | CA2285274A1 Human embryonic germ cell line and methods of use |
10/08/1998 | CA2285039A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | CA2284991A1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide |
10/08/1998 | CA2284728A1 Insect expression vectors |
10/08/1998 | CA2284686A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | CA2283934A1 Recombinant protein c and protein s variants |
10/08/1998 | CA2283799A1 Novel human serine carboxypeptidase |
10/08/1998 | CA2283463A1 Improved sar plant transformation process |
10/07/1998 | EP0869183A1 Genetic control of ethylene biosynthesis in plants |
10/07/1998 | EP0869181A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
10/07/1998 | EP0869180A1 A TNF homologue, TL5 |
10/07/1998 | EP0869179A1 Tumor necrosis related receptor, TR7 |
10/07/1998 | EP0869178A1 SAF-3, Sialoadhesin family member-3 |
10/07/1998 | EP0869177A2 Human a- and b- platelet-derived growth factor receptor proteins and uses therefor. |
10/07/1998 | EP0869175A2 Cytochrome C and its gene |
10/07/1998 | EP0869173A2 Carrier for cell cultures |
10/07/1998 | EP0868920A2 Hybrid protein for treatment of bladder cancer cells |
10/07/1998 | EP0868536A1 Genetic suppressor elements against human immunodeficiency virus |
10/07/1998 | EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
10/07/1998 | EP0868524A2 Improved barstar gene |
10/07/1998 | EP0868519A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
10/07/1998 | EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
10/07/1998 | EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
10/07/1998 | EP0868511A1 Utrophin gene expression |
10/07/1998 | EP0868508A1 Neuronal stimulation using electrically conducting polymers |
10/07/1998 | EP0868505A1 In vitro chondrogenic induction of human mesenchymal stem cells |
10/07/1998 | EP0868426A1 Chemically-inducible arabidopsis pr-1 promoter |
10/07/1998 | CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use |
10/07/1998 | CN1195374A Cytoplasmic modulators of integrin regulation/signaling |
10/07/1998 | CN1195295A Method and use of connective tissue growth factor as revellent |
10/07/1998 | CN1195026A Stress resistant plant in which cell death suppressing gene is introduced and method for producing same |
10/07/1998 | CN1040126C Process for preparing protein |
10/06/1998 | US5817912 Transgenic mice with disrupted NPY Y1 receptor genes |
10/06/1998 | US5817796 C-myb ribozymes having 2'-5'-linked adenylate residues |
10/06/1998 | US5817790 Reshaped human antibody to human interleukin-6 receptor |
10/06/1998 | US5817789 Bind to cell surface receptors; genetic engineering |
10/06/1998 | US5817784 Polypeptide termined neuritin which is expressed primary in brain tissue |
10/06/1998 | US5817773 Stimulation, production, culturing and transplantation of stem cells by fibroblast growth factors |
10/06/1998 | US5817768 Medical diagnosis |
10/06/1998 | US5817764 Cell culture substrates and methods of making such substracts |
10/06/1998 | US5817622 Cloning dna sequences |
10/06/1998 | US5817516 Methods for proliferating and differentiating B cells with high density membrane CD40 ligand |
10/06/1998 | US5817515 Human B2 integrin alpha subunit antibodies |
10/06/1998 | US5817513 Immunotherapy for cancer |
10/06/1998 | US5817509 Multiwell |
10/06/1998 | US5817502 Genes for the synthesis of pyrrolnitrin |
10/06/1998 | US5817496 Kynurenine aminotransferase |
10/06/1998 | US5817494 Anticancer agents; viricides |
10/06/1998 | US5817492 Recombinant DNA viral vector for transfecting animal cells |
10/06/1998 | US5817491 Enveloped vector particle; vesicular stomatitis virus |
10/06/1998 | US5817486 Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides |
10/06/1998 | US5817481 Medical diagnosis; detecting diseases related to mutants in nucleic acid sequences and altered concentration of polypeptides |